James C. Czirr, Executive Chairman at GALECTIN THERAPEUTICS INC (GALT), sold 100,000 shares at $16.00 ($1.5M) on 2014-01-10, disclosed to the SEC on 2014-01-14.
Open-market sale of $1.5M GALT by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 42,000 | $672K | 45.3% |
| 2 | $14.00 | 58,000 | $812K | 54.7% |
| Total | $14.84 avg | 100,000 | $1.5M | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |